How GLP-1 Trials Are Shaping Medicine—And How Fastrack Prepares Students to Contribute
The United States is currently at the forefront of a revolution in metabolic health, largely driven by the ongoing research and expanding applications of GLP-1 (glucagon-like peptide-1) receptor agonists. These groundbreaking medications, initially developed for type 2 diabetes, have truly transformed the treatment landscape for a range of conditions. Originally, GLP-1s like Ozempic and Trulicity … Read more